Skip to content
Stop using now Drug recall · FDA · Published February 18, 2015

Mylan Recalls Haloperidol Decanoate Injection Due to Sterility Risk

Mylan Institutional LLC recalls specific lots of Haloperidol Decanoate Injection due to leaking vials and lack of sterility assurance. Check your NDC and lot numbers.

🇺🇸 FDA recall #D-0421-2015DrugMylan Institutional ›
Take action

Contact the company

Recalling firmMylan Institutional LLC4901 Hiawatha Dr · Rockford, IL 61103-1287
✎ GovInfoNow plain-language explainer

Mylan Institutional LLC is recalling Haloperidol Decanoate Injection, 100 mg/mL, because the vials may be leaking, which compromises the assurance of sterility. The recall affects two specific lots distributed nationwide and in Puerto Rico. No remedy or return instructions are currently stated in the record. Read more at govinfonow.com/recall/44924-mylan-institutional-llc-recalls-haloperidol-decanoate-injection-100-mg-ml.

Source Summary by GovInfoNow · govinfonow.com/recall/44924-mylan-institutional-llc-recalls-haloperidol-decanoate-injection-100-mg-ml · Updated October 12, 2026 · FDA enforcement record: FDA #D-0421-2015

Cite this page

“Mylan Recalls Haloperidol Decanoate Injection Due to Sterility Risk.” GovInfoNow, updated October 12, 2026. https://govinfonow.com/recall/44924-mylan-institutional-llc-recalls-haloperidol-decanoate-injection-100-mg-ml. Based on FDA recall #D-0421-2015 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0421-2015%22&limit=1).

The FDA announced on Feb. 18, 2015, that Mylan Institutional LLC voluntarily recalled Haloperidol Decanoate Injection due to a lack of sterility assurance caused by leaking vials. The agency classified the recall as Class II.

How to tell if you have it

  • Brand: Mylan Institutional
  • Product: Haloperidol Decanoate Injection, 100 mg/mL, For Intra Muscular Use Only, 1 mL single dose vials
  • NDC: 67457-409-00 (vials), 67457-409-13 (cartons of five)
  • Lot codes: 7602281, 7602283
  • Expiration dates: 4/16
  • Distribution: Nationwide and Puerto Rico

The hazard

The recall addresses a lack of assurance of sterility due to leaking vials. The FDA classified the action as Class II.

Context

GovInfoNow's records show Mylan Institutional LLC has 10 other recalls on record since Jan. 23, 2015. Other recent recalls include a May 3, 2021 labeling error for Thiamine HCl Injection and an Aug. 17, 2020 label mix-up risk for Amiodarone Injection. Similar products have faced sterility issues, including a July 2, 2026 recall of Mycophenolate Mofetil Injection for precipitate risk and a Sept. 10, 2026 Quad-Mix Injectable recall by Carolina Infusion.

How to tell if you have this one

Check for Haloperidol Decanoate Injection, 100 mg/mL, For Intra Muscular Use Only, in 1 mL single dose vials. Look for NDC 67457-409-00 (single vial) or NDC 67457-409-13 (cartons of five). Affected lots are 7602281 and 7602283, both with an expiration date of 4/16.

  • Brand
    Mylan Institutional
  • Category
    Drug
FDA recall event · 2 products

All 2 products in this recall

FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.

  • Classification
    Class II
  • Status
    Terminated
  • Distribution
    Nationwide and Puerto Rico
  • NDC
    67457-410-00, 67457-410-13, 67457-409-00, 67457-409-13
Recall numberProduct, codes & lotsQuantity
D-0421-2015Haloperidol Decanoate Injection, 100 mg/mL, For Intra Muscular Use Only, 1 mL single dose vials (NDC 67457-409-00) packaged in cartons of five (NDC 67457-409-13), Rx only, Manufactured in India for: Mylan Institutional LLC Rockford, IL 61103; Lot 7602281, Exp 4/16; Lot 7602283, Exp 4/1611,030 cartons (55,150 vials)
D-0422-2015Haloperidol Decanoate Injection, 50 mg/mL, For Intra Muscular Use Only, 1 mL single dose vials (NDC 67457-410-00) packaged in cartons of ten (NDC 67457-410-13), Rx only, Manufactured in India for: Mylan Institutional LLC Rockford, IL 61103; Lot 7602368, Exp 7/16; Lot 7602369, Exp 7/162,523 cartons (25,936 vials)
Based on the official FDA remedy

What to do — step by step

  1. Stop using the product

    Do not use any vials from lots 7602281 or 7602283 due to the risk of non-sterile contents.

  2. Contact healthcare provider

    Inform your doctor or pharmacist about the recall to discuss alternative treatments or next steps.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFLPuerto Rico: yesPR

FDA distribution: “Nationwide and Puerto Rico” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 2 years after the firm started it.

1. Firm started the recall: Feb 18, 201512. FDA classified it Class II: Mar 23, 201523. Published in FDA’s Enforcement Report: Apr 1, 201534. FDA terminated the recall: Feb 23, 2017420152017
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

✎ GovInfoNow

Questions people ask

Which lot numbers are recalled?

The recalled lots are 7602281 and 7602283, both expiring in April 2016.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0421-2015 (February 18, 2015) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0421-2015 to see it in context.
  • Plain-language summary written by qwen3.6:35b-a3b on October 12, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA